Pharma Pricing and Reimbursement

Who should attend?

• Pricing, Market Access Professionals who want to learn about regional markets.
• Regulatory professionals who want to learn about commercial issues.
• Strategic planners who want to know where they might go next
• Those who want insight into the way that markets influence each other.
• Anyone who wants to understand global pricing issues.

Graduation in any discipline.

1. Attend the course 24×7 by login to your dashboard. Therefore, one can attend lectures, simulation, self assessment tests and final certification examination online at own convenience.
2. You will also be eligible to receive the course study modules, which you can download by login to your course page.

Course Features

This online course utilizes 24×7 interactive learning tools to guide each participant through the steps of market access, pricing, forecasting and reimbursement. Moreover this market access training challenges participants to apply what they have learned through the use of interactive exercises, reflection questions, expert live chat and a final assessment at the end of the course.

Important Learning Features: 

• The course provided comprehensive advanced understanding on global and national pricing, market access, pricing, forecasting.
• Advance practical training in health economics and evidence based pricing concepts.
• Advance training on market assessment to determine pricing models.
• Detailed training on forecasting models and techniques with practical case studies.
• Training on value dossier preparation.
• Health Economics.
• Health Technology Assessments.
• Patient Advocacy.

Related Courses

At Royed Training, we have 1 year PG Cortication in Pharma Market Access.

Followings are the few of the similar courses, you may be interested in

• Pharma Market Access and Pricing >> Click here
• Pharma Global Management >> Click here
• Biopharma Global Business Course >> Click here
• Drug Regulatory Affairs Course >> Click here
• Online Training on CE certification >> Click here
• Medical devices regulatory affairs >> Click here
• Drug, Biologic and Medical Devices Regulatory Affairs Course >> Click here
• USFDA Pharmaceutical and Biopharmaceutical Regulatory Affairs >> Click here

PPR – Pharma Pricing and Reimbursement

Pharmaceutical pricing and reimbursement are complex topics that involve government policies, insurance systems, pharmaceutical companies, healthcare providers, and patients. These elements vary significantly from country to country, making it essential to consider the specific context in which pharmaceuticals are priced and reimbursed. Here’s a general overview of these concepts:

Pharmaceutical Pricing: Pharmaceutical pricing refers to the cost set by pharmaceutical manufacturers for their drugs and medications. Several factors influence drug pricing:

1. Research and Development Costs: The expenses incurred during drug development, including clinical trials, play a significant role in determining drug prices.
2. Production and Manufacturing Costs: The cost of producing and manufacturing the drug affects its pricing. This includes the cost of raw materials, labor, and facilities.
3. Competition: The level of competition in the market for a particular drug can impact pricing. In markets with multiple similar drugs (generic competition), prices tend to be lower.
4. Market Demand: The demand for a drug and its therapeutic benefits can influence pricing. Drugs for rare diseases or life-threatening conditions may be priced higher.
5. Regulatory and Patent Protection: Pharmaceutical companies often hold patents that grant them exclusive rights to sell a drug for a certain period. This exclusivity can allow them to set higher prices.
6. Government Regulations: Different countries have various regulations that affect drug pricing. Some countries regulate prices directly, while others negotiate prices with pharmaceutical companies.

Pharmaceutical Reimbursement: Reimbursement involves how the costs of pharmaceuticals are covered, either by public or private health insurance systems, or out-of-pocket payments by patients. Key factors in pharmaceutical reimbursement include:

1. Healthcare Systems: The structure of a country’s healthcare system, whether it’s public, private, or a mix of both, impacts how pharmaceuticals are reimbursed.
2. Health Insurance: Health insurance plans, whether provided by the government or private insurers, determine how much of a drug’s cost is covered for the patient.
3. Formularies: Many health insurance plans have formularies, which are lists of approved drugs. Drugs not on the formulary may not be reimbursed, or they may have higher patient copayments.
4. Cost-Sharing: Patients may be required to pay a portion of the drug’s cost, such as copayments or deductibles, when they obtain prescription medications.
5. Government Programs: In some countries, government programs like Medicaid in the United States or the National Health Service (NHS) in the UK, provide healthcare coverage, including reimbursement for pharmaceuticals.
6. Price Negotiations: In some countries, governments negotiate directly with pharmaceutical companies to set drug prices, aiming to control healthcare costs.
7. Pharmaceutical Benefit Management: Organizations may be involved in managing drug benefits for insurers and employers, influencing which drugs are covered and how they are reimbursed.

This course on Pharmaceutical pricing and reimbursement policies provides brainstorming sessions on healthcare costs, access to medications, and the financial sustainability of healthcare systems. Most importantly course ensures understanding on how how to manage the Governments, healthcare providers, pharmaceutical companies, and patients to ensure safe access to essential medications and controlling healthcare expenditures.